Cdk1: the dominant sibling of Cdk2

被引:0
|
作者
Tarig Bashir
Michele Pagano
机构
[1] New York University School of Medicine and NYU Cancer Institute,Department of Pathology
[2] MSB 599,undefined
来源
Nature Cell Biology | 2005年 / 7卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Cdk2 is thought to regulate entry into S phase, whereas Cdk1 controls the initiation of mitosis. New evidence shows that Cdk1 is equally capable of promoting the G1/S transition in Cdk2−/− cells, raising the question as to whether Cdk1 constitutes the predominant cyclin-dependent kinase in mammalian cells, or only compensates for Cdk2 function when it is compromised.
引用
收藏
页码:779 / 781
页数:2
相关论文
共 50 条
  • [1] Cdk1: the dominant sibling of Cdk2
    Bashir, T
    Pagano, M
    NATURE CELL BIOLOGY, 2005, 7 (08) : 779 - 781
  • [2] Discovery and evaluation of dual CDK1 and CDK2 inhibitors
    Payton, M
    Chung, G
    Yakowec, P
    Wong, A
    Powers, D
    Xiong, L
    Zhang, N
    Leal, J
    Bush, TL
    Santora, V
    Askew, B
    Tasker, A
    Radinsky, R
    Kendall, R
    Coats, S
    CANCER RESEARCH, 2006, 66 (08) : 4299 - 4308
  • [3] Genetic substitution of Cdk1 by Cdk2 leads to embryonic lethality and loss of meiotic function of Cdk2
    Satyanarayana, Ande
    Berthet, Cyril
    Lopez-Molina, Javier
    Coppola, Vincenzo
    Tessarollo, Lino
    Kaldis, Philipp
    DEVELOPMENT, 2008, 135 (20): : 3389 - 3400
  • [4] Critical reanalysis of the methods that discriminate the activity of CDK2 from CDK1
    Sakurikar, Nandini
    Eastman, Alan
    CELL CYCLE, 2016, 15 (09) : 1184 - 1188
  • [5] The Cdk1/Cdk2 homolog CDKA;1 controls the recombination landscape in Arabidopsis
    Wijnker, Erik
    Harashima, Hirofumi
    Mueller, Katja
    Parra-Nunez, Pablo
    Bastiaan de Snoo, C.
    van de Belt, Jose
    Dissmeyer, Nico
    Bayer, Martin
    Pradillo, Monica
    Schnittger, Arp
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (25) : 12534 - 12539
  • [6] Discovery of a novel class of 2-aminopyrimidines as CDK1 and CDK2 inhibitors
    Lee, Jinho
    Kim, Kyoung-Hee
    Jeong, Shinwu
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (14) : 4203 - 4205
  • [7] Cdk1, but not Cdk2, is the sole Cdk that is essential and sufficient to drive resumption of meiosis in mouse oocytes
    Adhikari, Deepak
    Zheng, Wenjing
    Shen, Yan
    Gorre, Nagaraju
    Ning, Yao
    Halet, Guillaume
    Kaldis, Philipp
    Liu, Kui
    HUMAN MOLECULAR GENETICS, 2012, 21 (11) : 2476 - 2484
  • [8] CDK1 AND CDK2 ACTIVITY IS A STRONG PREDICTOR OF RENAL CELL CANCER RECURRENCE
    Hongo, F.
    Takaha, N.
    Kimura, Y.
    Nakamura, T.
    Mikami, K.
    Nakayama, S.
    Matsushima, T.
    Ishihara, H.
    Sakai, T.
    Miki, T.
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 138 - 139
  • [9] CDK1 and CDK2 activity is a strong predictor of renal cell carcinoma recurrence
    Hongo, Fumiya
    Takaha, Natsuki
    Oishi, Masakatsu
    Ueda, Takashi
    Nakamura, Terukazu
    Naitoh, Yasuyuki
    Naya, Yoshio
    Kamoi, Kazumi
    Okihara, Koji
    Matsushima, Tomoko
    Nakayama, Satoshi
    Ishihara, Hideki
    Sakai, Toshiyuki
    Miki, Tsuneharu
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (08) : 1240 - 1246
  • [10] Use of CDK1 and CDK2 activity to predict renal cell cancer recurrence
    Hongo, F.
    Takaha, N.
    Kimura, Y.
    Nakamura, T.
    Mikami, K.
    Nakayama, S.
    Matsushima, T.
    Ishihara, H.
    Sakai, T.
    Miki, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)